ADAM9 (also known as metalloprotease/disintegrin/cysteine-rich protein 9 (MDC9) or meltrin-γ), one of the ADAM proteins, was first identified in 1996 in breast carcinoma [10]. The gene discussed is ADAM9; the disease is breast carcinoma.